Print ISSN:-2394-4781

Online ISSN:-2394-4994

CODEN : IJCACT

Article History

Received : 02-08-2022

Accepted : 22-08-2022



Article Metrics




Downlaod Files

   


Article Access statistics

Viewed: 431

PDF Downloaded: 177


Perioperative management of post covid mucormycosis patient with dilated cardiomyopathy and atrial fibrillation posted for endoscopic debridement- A case report


Full Text PDF Share on Facebook Share on Twitter


Case Report

Author Details : Mitali Dilipkumar Agrawal*, Ranjeeta M Tambey

Volume : 9, Issue : 4, Year : 2022

Article Page : 504-507

https://doi.org/10.18231/j.ijca.2022.100



Suggest article by email

Get Permission

Abstract

Anaesthesiologists being the frontline worker in COVID 19 pandemic, also contributed to the management of post-COVID sequelae like mucormycosis. Hereby reporting a case of successful anaesthetic management of a 60-year-old male with post COVID mucormycosis having an orbital extension, with co-morbidities like IHD, dilated cardiomyopathy, rate-controlled atrial fibrillation on regular treatment posted for emergency endoscopic debridement. Patient received amphotericin lipid complex. Preoperative 2D ECHO suggestive of ejection fraction of 23%, dilated LV, severe LV systolic dysfunction, mild MR, TR, AR, non-valvular atrial fibrillation, and no LA clot. While shifting the patient postoperatively, patient had a cardiorespiratory arrest, revived after 2 cycles of CPR and had atrial fibrillation with fast ventricular rate which was successfully cardioverted to normal sinus rhythm after synchronized cardioversion. Such cases always pose a challenge to anaesthesiologists as post covid systemic complications superadded with cardiac co-morbidities increase the overall risk.
 

Keywords: Dilated cardiomyopathy, COVID­ 19, Mucormycosis.



How to cite : Agrawal M D, Tambey R M, Perioperative management of post covid mucormycosis patient with dilated cardiomyopathy and atrial fibrillation posted for endoscopic debridement- A case report. Indian J Clin Anaesth 2022;9(4):504-507


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.